
NYSE:GS
29 expert ratings on Goldman Sachs (GS) in the last 12 months: 23 Buy, 3 Hold, 3 Sell. Latest rating: BUY by Stephen Weiss, Founder, Short Hills Capital Partners on Sep 14, 2026.
Different businesses. LLY is a big play in GLP-1 drugs. How will pills effect the injections business? LLY has done a good job of navigating these new pills. GS enjoys increased stock market and IPO businesses. He prefers LLY, which is tied to a secular growth trend, but GS' good times in capturing revenue in this cycle will end.
Mergers are increasing, and banks like GS makes advisory fees from them. Also, the banks have been rallying since oil slumped, and will benefit further from rising interest rates, which appears will happen later this year. Plus, hyperscalers may need to keep borrowing money to keep competing with each other.
Goldman Sachs is a American stock, trading under the symbol GS (previously GS-N on Stockchase) on the New York Stock Exchange (GS). It is usually referred to as NYSE:GS or GS
29 expert ratings on Goldman Sachs (GS) in the last 12 months: 23 Buy, 3 Hold, 3 Sell. Latest rating: BUY by Stephen Weiss, Founder, Short Hills Capital Partners on Sep 14, 2026. Read the latest stock experts' ratings for Goldman Sachs.
Goldman Sachs was recommended as a Top Pick by Stephen Weiss, Founder, Short Hills Capital Partners on 2026-09-14. Read the latest stock experts ratings for Goldman Sachs.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Goldman Sachs.
Goldman Sachs is followed by 229 investors on Stockchase and is a trending stock that is worth watching.
On 2026-09-18, Goldman Sachs (GS) stock closed at a price of $942.00.
The banks look great here. A higher interest rate will make the banks a little more money, not a lot. The banks are a hedge on the economy. They have enough M&A activity and IPOs, too.